๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Gastric cancer in the era of molecularly targeted agents: current drug development strategies

โœ Scribed by Hendrik-Tobias Arkenau

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
399 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Development of molecularly targeted ther
Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities
โœ Andrew X. Zhu; Aram F. Hezel ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 184 KB

Biliary tract cancers (BTCs), which encompass intra- and extrahepatic cholangiocarcinomas as well as gallbladder carcinomas, are a genetically diverse collection of cancers. Most patients with BTC will present with unresectable or metastatic disease. Although the standard systemic chemotherapy appro

Natural agents targeting the ฮฑ7-nicotini
Natural agents targeting the ฮฑ7-nicotinic-receptor in NSCLC: A promising prospective in anti-cancer drug development
โœ Alessia Grozio; Laura Paleari; Alessia Catassi; Denis Servent; Michele Cilli; Fe ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 446 KB

## Abstract Nicotinic acetylcholine receptors (nAChR) are expressed on normal bronchial epithelial and nonsmall cell lung cancer (NSCLC) cells and are involved in cell growth regulation. Nicotine induced cell proliferation. The purpose of this study was to determine if interruption of autocrine nic